PhRMA Urges FTC Not To Expand Patent Licensing Scrutiny
The Pharmaceutical Research and Manufacturers of America accused the Federal Trade Commission on Wednesday of exceeding its authority under federal merger law and discriminating against the industry by proposing to expand...To view the full article, register now.
Already a subscriber? Click here to view full article